Miguel Vargas-Mejía

8PUBLICATIONS
35CO-AUTHORS
Molecular targetsEpigenetics (incl. genome methylation and epigenomics)Medical infection agents (incl. prions)Cancer therapy (excl. chemotherapy and radiation therapy)Structure and dynamics of materials
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Nov 27, 2025
MicroRNAs Let-7b-5p and miR-24-3p as Potential Therapeutic Agents Targeting Pancreatic Cancer Stem Cells.

Maricela Medrano-Silva, Eric Genaro Salmerón-Bárcenas, Elena Arechaga-Ocampo

|Nov 13, 2025
DNMT Enzymes and Their Impact on Cervical Cancer: A State-of-the-Art Review.

Eric Genaro Salmerón-Bárcenas, Andrea Martínez-Zayas, Miguel Vargas-Mejía

|Oct 28, 2023
Circulating miRNAs as Noninvasive Biomarkers for PDAC Diagnosis and Prognosis in Mexico.

Lissuly Guadalupe Álvarez-Hilario, Eric Genaro Salmerón-Bárcenas, Pedro Antonio Ávila-López

|Oct 09, 2023
Synergistic effect of antagonists to KRas4B/PDE6 molecular complex in pancreatic cancer.

Paola Briseño-Díaz, Michael Schnoor, Martiniano Bello-Ramirez

|Sep 09, 2022
131I-C19 Iodide Radioisotope and Synthetic I-C19 Compounds as K-Ras4B-PDE6δ Inhibitors: A Novel Approach against Colorectal Cancer-Biological Characterization, Biokinetics and Dosimetry.

Pedro Cruz-Nova, Blanca Ocampo-García, Dayan Andrea Carrión-Estrada

|Dec 04, 2018
Acetylation is the most abundant actin modification in Entamoeba histolytica and modifications of actin's amino-terminal domain change cytoskeleton activities.

Nora Adriana Hernández-Cuevas, Gagan Deep Jhingan, Debora Petropolis

Pageof 2

Frequent Collaborators

5 joint publications

Rosaura Hernandez-Rivas

3 joint publications

Nicolas Villegas-Sepúlveda

3 joint publications

Paola Briseño-Díaz

2 joint publications

Arturo Aguilar-Rojas